EDIT vs WELL
Editas Medicine Inc (EDIT) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
EDIT currently screens at market cap $375.2M. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the EDIT and WELL stock pages for the full models.
Not investment advice.